tradingkey.logo

Intelligent Bio Solutions Inc

INBS

1.320USD

-0.100-7.04%
終値 09/19, 16:00ET15分遅れの株価
9.67M時価総額
損失額直近12ヶ月PER

Intelligent Bio Solutions Inc

1.320

-0.100-7.04%
詳細情報 Intelligent Bio Solutions Inc 企業名
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
企業情報
企業コードINBS
会社名Intelligent Bio Solutions Inc
上場日Dec 23, 2020
最高経営責任者「CEO」Mr. Harry Simeonidis
従業員数16
証券種類Ordinary Share
決算期末Dec 23
本社所在地135 W 41St St,
都市NEW YORK
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号10036
電話番号16467905756
ウェブサイトhttps://ibs.inc/
企業コードINBS
上場日Dec 23, 2020
最高経営責任者「CEO」Mr. Harry Simeonidis
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
データなし
地域別USD
会社名
収益
比率
United Kingdom
692.16K
94.96%
Other
31.43K
4.31%
Australia
5.28K
0.72%
事業別
地域別
データなし
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Alyeska Investment Group, L.P.
6.80%
Sakiris (Spiro Kevin)
0.60%
Geode Capital Management, L.L.C.
0.57%
Simeonidis (Harry)
0.45%
The Vanguard Group, Inc.
0.17%
他の
91.41%
株主統計
株主統計
比率
Alyeska Investment Group, L.P.
6.80%
Sakiris (Spiro Kevin)
0.60%
Geode Capital Management, L.L.C.
0.57%
Simeonidis (Harry)
0.45%
The Vanguard Group, Inc.
0.17%
他の
91.41%
種類
株主統計
比率
Hedge Fund
6.92%
Individual Investor
1.05%
Investment Advisor/Hedge Fund
0.57%
Investment Advisor
0.20%
Research Firm
0.14%
Venture Capital
0.10%
他の
91.01%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
2023Q2
43
60.27K
19.45%
+30.17K
2023Q1
42
45.22K
32.24%
+33.92K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Alyeska Investment Group, L.P.
613.89K
8.88%
+613.89K
--
Mar 31, 2025
Sakiris (Spiro Kevin)
53.93K
0.78%
+171.00
+0.32%
Mar 18, 2025
Geode Capital Management, L.L.C.
49.01K
0.71%
+22.41K
+84.25%
Mar 31, 2025
Simeonidis (Harry)
40.41K
0.58%
+59.00
+0.15%
Mar 18, 2025
The Vanguard Group, Inc.
15.48K
0.22%
--
--
Mar 31, 2025
Goldman Sachs & Company, Inc.
12.82K
0.19%
+12.82K
--
Mar 31, 2025
Ionic Ventures LLC
9.40K
0.14%
+9.40K
--
Dec 31, 2023
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
日付
種類
比率
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
KeyAI